WEST PHARMACEUTICAL SERVICES, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $4.00 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2019-02-28
- WEST PHARMACEUTICAL SERVICES, INC. effective income tax rate reconciliation, other adjustments, amount for the quarter ending 2012-12-31 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. effective income tax rate reconciliation, other adjustments, amount for the quarter ending 2012-09-30 was $0.00, a 100.00% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. effective income tax rate reconciliation, other adjustments, amount for the quarter ending 2012-06-30 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. effective income tax rate reconciliation, other adjustments, amount for the quarter ending 2012-03-31 was $300.00K, a 50.00% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2018 was $4.00M.
- WEST PHARMACEUTICAL SERVICES, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2014 was $1.00M, a 71.43% decline from fiscal 2013.
- WEST PHARMACEUTICAL SERVICES, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2013 was $3.50M, a 1066.67% increase from fiscal 2012.
- WEST PHARMACEUTICAL SERVICES, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2012 was $300.00K.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 3 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 6 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 9 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month |
|---|---|---|---|---|
| 2018-12-31 | $4.00M 10-K · filed 2019-02-28 | |||
| 2014-12-31 | $1.00M 10-K · filed 2017-02-28 | |||
| 2013-12-31 | $3.50M 10-K · filed 2016-02-26 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $0.00 derived: sum of 2 quarters · filed 2015-02-25 | $0.00 derived: sum of 3 quarters · filed 2015-02-25 | $300.00K 10-K · filed 2015-02-25 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | $0.00 derived: sum of 2 quarters · filed 2013-11-04 | $300.00K 10-Q · filed 2013-11-04 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | $300.00K 10-Q · filed 2013-08-05 | ||
| 2012-03-31 | $300.00K 10-Q · filed 2013-05-06 | |||
| 2011-09-30 | $700.00K 10-Q · filed 2011-11-07 | $700.00K derived: sum of 2 quarters · filed 2012-08-06 | $800.00K 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $200.00K 10-Q · filed 2012-08-06 | ||
| 2011-03-31 | $200.00K 10-Q · filed 2012-05-04 | |||
| 2010-09-30 | -$500.00K 10-Q · filed 2011-11-07 | $0.00 derived: sum of 2 quarters · filed 2011-11-07 | ||
| 2010-06-30 | $500.00K 10-Q/A · filed 2011-08-08 | $500.00K 10-Q/A · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |